Regeneron at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Regeneron brings 13 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on immunogenicity and bioanalysis for biologics, including how anti-drug antibody tests are run and read. Its sessions also weigh whether new non-animal methods can replace animal data and present a product-agnostic manufacturing platform for clinical supply.

OrganizationAAPS 2026 PharmSci 360 Attendance
Regeneron
Tarrytown, NY
Large pharma
Biotechnology company discovering and marketing antibody medicines for eye disease, allergic and inflammatory diseases, and cancer.
Session
Mon Oct 26
10:00am–11:00am
Hot Topic: Beyond Animal Models? Pros-Cons, and Regulatory Implications of NAM-Based Strategies
Bioanalytics · with EpiVax
Talk
Mon Oct 26
10:00am–10:15am
Part of Hot Topic: Beyond Animal Models? Pros-Cons, and Regulatory Implications of NAM-Based Strategies
NAM Pros and Cons: Case Studies from Industry
210
Bioanalytics
Talk
Mon Oct 26
10:30am–11:00am
Part of Hot Topic: Beyond Animal Models? Pros-Cons, and Regulatory Implications of NAM-Based Strategies
Panel Debate: Are We Moving Away from Animal Data Too Fast?
210
Bioanalytics · with EpiVax
Poster
Mon Oct 26
1:30pm–2:30pm
Built for Speed, Grounded in Science: A Product-Agnostic DP Manufacturing Platform for Clinical Supply Delivery
Solution Center · Poster M1330-04-23
Manufacturing and Analytical Characterization - Biomolecular
Session
Mon Oct 26
3:00pm–4:00pm
Rapid Fire: Advancing Bioanalysis for Next-Generation Therapeutics
Bioanalytics
Session
Tue Oct 27
9:00am–10:00am
Hot Topic: Immunogenicity Expectations: Are They Fact or Fear?
Bioanalytics · with ThinkCMC4FDA
Talk
Tue Oct 27
9:30am–10:00am
Part of Hot Topic: Immunogenicity Expectations: Are They Fact or Fear?
Panel Discussion: Industry Perspectives
210
Bioanalytics · with ThinkCMC4FDA
Talk
Tue Oct 27
10:30am–11:00am
Part of Symposium: Oligonucleotide Bioanalysis: Ring Trial and Emerging Conjugate Modalities
Fit-for-Purpose or Box-Checking? Metabolite Assessment Strategy for Oligonucleotides
211-213
Bioanalytics
Talk
Tue Oct 27
3:30pm–3:45pm
Part of Rapid Fire: Turning Bioanalytical Challenges into Reliable Answers
Survey of Approved Biologics: Targeting Cell Receptor Increases ADA Development
211-213
Bioanalytics
Talk
Tue Oct 27
3:45pm–4:00pm
Part of Rapid Fire: Turning Bioanalytical Challenges into Reliable Answers
Does Improved ADA Drug Tolerance Change Clinical Immunogenicity Conclusions? A Case Study with REGN-X
211-213
Bioanalytics
Talk
Wed Oct 28
9:30am–10:00am
Part of Symposium: Biomarker-to-Decision: Biomarker Contexts of Use and Fit-for-Purpose Strategies
Measurement of an Intracellular Biomarker in Liver Tissue
203-205
Bioanalytics
Poster
Wed Oct 28
9:30am–10:30am
Quantitative IL-12p70 Measurement Using a Drug-Tolerant, Digoxigenin-Amplified Immunoassay in the Presence of an Anti-IL-12 Monoclonal Antibody
Solution Center · Poster W0930-06-34
Bioanalytics - Biomolecular
Talk
Wed Oct 28
3:45pm–4:00pm
Part of Rapid Fire: Beyond Conventional Samples: Approaches in Tissue Bioanalysis and Biosensing
A Sample-Sparing Dual-Assay Strategy for Quantifying Tissue GAA Expression and Enzymatic Activity
211-213
Bioanalytics

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Regeneron

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction